SL Investment
VC Fund
Seoul, South Korea
SL Investment is a VC fund in Seoul focused on Biotechnology and Medical. SL investment (SLi) aims at a company with global standards through management by principle and transparency.SLi is a venture capital firm founded in February 2000 and has widely invested in the companies from early to mezzanine stage, in the field of semiconductors, display (AMOLED, LED, LCD), renewable energy, and health care industry.Since its incorporation, SLi has recorded black-ink balances for 12 consecutive years with zero debt and also has successfully dissolved all the five funds with outstanding earning rates.SLi tries to raise the value of venture companies not only by offering funds but by supporting the management omnidirectionally after its investment. Consequently, 31 companies have been successfully listed in KOSDAQ market for 12 years and all the companies have positioned as leading firms in their specific fields.
- Total investments:
- 78
- Last investment:
- Lead investor:
- 8%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries SL Investment invests in
Stages SL Investment invests in
Countries SL Investment invests in
Round sizes
Contacts
3 more contacts available
Round size
- Seed
- $2k–$13M
- Series A
- $1.9M–$17M
- Series B
- $4.2M–$27M
Investment Focus
Industry
- Biotechnology 10 (13%)
- Medical 9 (12%)
- Software 8 (10%)
- Health Care 8 (10%)
- Manufacturing 8 (10%)
Stage
- Series A 26 (33%)
- Series B 25 (32%)
- Seed 8 (10%)
- Funding Round 4 (5%)
- Series C 3 (4%)
Country
- South Korea 56 (72%)
- United States 5 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
JW Kim
CEO and President
|
CEO and President | Total investments: 0 | Find email | |
Minju Ahn
Managing Director
|
Managing Director | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
StepLab
|
StepLab is a microsatellite systems company specializing in space mechanism technology, developing innovative satellite platforms and advanced aerospace solutions that support efficient satellite deployment, in-orbit operations, and a wide range of commercial and scientific space missions. | $7.7M / Series A / Aug 05, 2026 | |
Cenyx Biotech
|
Cenyx Biotech develops diagnostic and therapeutic nano-compounds formed based on nanozymes and nanoparticles. | $8.2M / Series B / Mar 31, 2026 | |
Twinny
|
Twinny specializes in the development of self-driving robots. | $13.6M / Series C / Mar 13, 2026 | |
Ark
|
Ark is an AI-based early screening company focused on identifying and preventing complications associated with chronic diseases, developing and supplying advanced medical AI solutions that enable early detection, risk assessment, and proactive disease management to support healthcare providers in delivering more precise and timely care. | $13.5M / Series A / Mar 05, 2026 | |
Galux
|
Galux provides molecular design technology focusing on discovering and developing novel drugs for incurable and rare diseases using its AI-based drug design platform technologies. | $29M / Series B / Feb 09, 2026 | |
SCBIO
|
SCBIO is a pharmaceutical company that makes drugs with specialized technologies in immuno-oncology. The company discovers and develops novel therapeutics for future medicine. | Series B / Sep 01, 2025 | |
|
SCBIO
|
SCBIO is a pharmaceutical company that makes drugs with specialized technologies in immuno-oncology. The company discovers and develops novel therapeutics for future medicine. | $10M / Seed / Sep 01, 2025 | |
Microt
|
Microt is a medical device company focused mainly on eye-related (ophthalmology) treatments—especially glaucoma. The company Develops medical technologies for glaucoma, a condition that damages the optic nerve due to high eye pressure. | $7.9M / Series B / Jul 31, 2025 | |
Ettifos
|
They are a talented group of entrepreneurs and engineers with state-of-the art technologies that they hope will contribute towards a better future in the connected-car ecosystem. They provide smart solutions for companies of all sizes and pride theirselves on their unparalleled, dedicated connected-car solutions.At Ettifos Co., they believe thatthe right understanding of the customer's need can lead companies towards a successful future. They always seek valuable feedback from their partners in order to learn and evolve. Contact us today to set up a meeting with one of their representatives or request a demo. | $11M / Series B / Jul 02, 2025 | |
AIRS Medical
|
AIRS Medical is an MRI reconstruction software service provider. | $3.4K / Venture - Series Unknown / Mar 12, 2025 | |
| See all 78 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does SL Investment invest in?
SL Investment invests primarily in Biotechnology, Medical and Software startups, most often at Series A and Series B stage. Most of the 78 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is SL Investment's check size?
SL Investment typically joins rounds of $2k–$13M at Seed, $1.9M–$17M at Series A and $4.2M–$27M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds SL Investment participates in.
How do I contact SL Investment?
Public channels for SL Investment include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at SL Investment?
The team at SL Investment includes JW Kim (CEO and President) and Minju Ahn (Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
